MBP metabolic pharmaceuticals limited

Gominer, I'm afraid you are wrong re phase III clinical trial...

  1. 13,013 Posts.
    lightbulb Created with Sketch. 99
    Gominer, I'm afraid you are wrong re phase III clinical trial for Metabolic's compound. It will most certainly require the full gamut of traditional testing particularly because many of our own hormones exert unwanted actions if given outside the normal endogenous levels and secretion protocols. eg steroid hormones and growth hormone itself (of which the Metabolic compound is a fraction) will cause untoward effects if given exogenously at abnormal levels.

    Bottom line, no shortcuts...

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.